Sofinnova Management IX, L.L.C.
CIK 1612134 · last filed 2020-08-12
Sofinnova Management IX, L.L.C. is a corporate insider who has filed 4 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for CMPI, was dated Aug 12, 2020. Across all open-market trades the lifetime net is +$75.4M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $24.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$24.14M
4
4
$75.40M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Checkmate Pharmaceuticals, Inc. (CMPI) Delisted | 10%+ Owner | 3,473,374 | $10.50 | $36.47M | $8.00M | 1 | 2020-08-12 |
| Iterum Therapeutics plc (ITRM) Delisted | 10%+ Owner | — | $0.03 | — | $0 | 1 | 2020-01-23 |
| Galera Therapeutics, Inc. (GRTX) Delisted | 10%+ Owner | 3,083,712 | $0.14 | $447.1K | $45.00M | 1 | 2019-11-12 |
| LIFE | 10%+ Owner | 1,546,126 | $15.61 | $24.14M | $22.40M | 1 | 2015-05-14 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-08-12 | Checkmate Pharmaceuticals, Inc. (CMPI) Delisted | Mixed | +14,426,828 | $8.00M | EDGAR |
| 2020-01-23 | Iterum Therapeutics plc (ITRM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-11-12 | Galera Therapeutics, Inc. (GRTX) Delisted | Mixed | +15,418,560 | $45.00M | EDGAR |
| 2015-05-14 | LIFE | Mixed | +9,330,630 | $22.40M | EDGAR |